This post was originally published on this site
Eli Lilly sees FY 2023 EPS of $9.70-$9.90 versus the analyst consensus of $8.71.
Eli Lilly sees FY 2023 revenue of $33.40B-$33.90B versus the analyst consensus of $31.44B.
Eli Lilly’s stock price closed at $454.08. It is up 4.25% in the last 3 months and up 49.85% in the last 12 months.
Eli Lilly saw 11 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Eli Lilly’s stock price’s past reactions to earnings here.
According to InvestingPro, Eli Lilly’s Financial Health score is “good performance“.
Check out Eli Lilly’s recent earnings performance, and Eli Lilly’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
